KPKexin Peng

Kexin Peng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kexin Peng has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Wenghong Wong

    Department of Dermatology Huashan Hospital, Shanghai Institute of Dermatology, Fudan University Shanghai China

    2 shared publications
  • Zhenghua Zhang

    Department of Dermatology, Huashan Hospital, Fudan University, Shanghai Institute of Dermatology , Shanghai

    2 shared publications
  • Jiewen Pan

    Department of Dermatology Huashan Hospital, Shanghai Institute of Dermatology, Fudan University Shanghai China

    1 shared publication
  • Jing Luan

    Department of Dermatology Huashan Hospital, Shanghai Institute of Dermatology, Fudan University Shanghai China

    1 shared publication
  • Kaihang Yang

    Department of Dermatology Huashan Hospital, Shanghai Institute of Dermatology, Fudan University Shanghai China

    1 shared publication
  • Kexiang Yan

    Department of Dermatology, Huashan Hospital, Fudan University, Shanghai Institute of Dermatology , Shanghai , People’s Republic of China

    1 shared publication

Latest Publications

  • Open Access

    Establishment of a Mouse Model for Porokeratosis Due to Mevalonate Diphosphate Decarboxylase Deficiency

    by Kexin Peng, Wenghong Wong, Qiaoan Zhang, Yumeng La, Zhen Tian, Ruilin Sun, Loksi Ho, Kaihang Yang, Jiewen Pan, Jing Luan, et al.

    Introduction: Porokeratosis (PK) is an autoinflammatory keratinization disease (AIKD) characterized by circular or annular skin lesions with a hyperkeratotic rim, pathologically shown as the cornoid lamella. Four genes that cause PK are associated with the mevalonate (MV) pathway. In Chinese PK patients, mevalonate diphosphate decarboxylase ( MVD ) is the most common causative gene. The lack of an animal model has greatly limited research on PK pathogenesis. Materials and Methods: In this research, we constructed K14‐CreER T2 ‐ Mvd fl/fl mice using the Cre‐LoxP system to create a mouse model for in‐depth studies of PK. The Epidermal Mvd gene was knocked out by intraperitoneal injection of Tamoxifen (TAM). Pathology, immunohistochemistry, RNA‐seq, and Western Blot analysis were performed. Results: Skin lesions appeared following Mvd deficiency, and pathological examination revealed the characteristic cornoid lamella, as well as cutaneous inflammation. Furthermore, we observed elevated levels of IL‐17A and IL‐1β, and a decreased Loricrin level in epidermal Mvd‐deficient mice. Compared with the wild‐type (WT) group, Mvd deficiency activated the expression of lipid metabolism‐related proteins. Conclusion: We developed the first mouse model for PK research, enabling further studies on disease development and treatment approaches.


  • Effective treatment of solar facial porokeratosis in one patient with topical atorvastatin/cholesterol cream

    by Kexin Peng, Wenghong Wong, Kexiang Yan, Zhenghua Zhang

    We report a rare case of solar facial porokeratosis (SFP) treated topically with atorvastatin/cholesterol or cholesterol alone for 48 weeks. The patient reported no obvious skin irritation and was delighted with the outcome. This study supported the effectiveness of a pathogenesis-directed treatment for SFP. Moreover, we point out that topical statins combined with cholesterol might have a long-term benefit in the treatment of SFP.